Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 2
2019 2
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis.
Di Benedetto P, Ruscitti P, Berardicurti O, Panzera N, Grazia N, Di Vito Nolfi M, Di Francesco B, Navarini L, Maurizi A, Rucci N, Teti AM, Zazzeroni F, Guggino G, Ciccia F, Dolo V, Alesse E, Cipriani P, Giacomelli R. Di Benedetto P, et al. Among authors: panzera n. Arthritis Res Ther. 2021 Aug 14;23(1):213. doi: 10.1186/s13075-021-02587-8. Arthritis Res Ther. 2021. PMID: 34391476 Free PMC article.
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6.
Ruscitti P, Liakouli V, Panzera N, Angelucci A, Berardicurti O, Di Nino E, Navarini L, Vomero M, Ursini F, Mauro D, Dolo V, Ciccia F, Giacomelli R, Cipriani P. Ruscitti P, et al. Among authors: panzera n. Pharmaceuticals (Basel). 2022 May 18;15(5):622. doi: 10.3390/ph15050622. Pharmaceuticals (Basel). 2022. PMID: 35631449 Free PMC article.
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Di Benedetto P, Guggino G, Manzi G, Ruscitti P, Berardicurti O, Panzera N, Grazia N, Badagliacca R, Riccieri V, Vizza CD, Radchenko G, Liakouli V, Ciccia F, Cipriani P, Giacomelli R. Di Benedetto P, et al. Among authors: panzera n. Arthritis Res Ther. 2020 Jun 1;22(1):127. doi: 10.1186/s13075-020-02218-8. Arthritis Res Ther. 2020. PMID: 32487240 Free PMC article.
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling.
Di Benedetto P, Panzera N, Cipriani P, Mastroiaco V, Tessitore A, Liakouli V, Ruscitti P, Berardicurti O, Carubbi F, Guggino G, Bianchi A, Di Marco A, Ciccia F, Alesse E, Giacomelli R. Di Benedetto P, et al. Among authors: panzera n. Sci Rep. 2019 May 9;9(1):7144. doi: 10.1038/s41598-019-43638-0. Sci Rep. 2019. PMID: 31073190 Free PMC article.
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: a new potential target for antifibrotic therapy.
Di Benedetto P, Liakouli V, Ruscitti P, Berardicurti O, Carubbi F, Panzera N, Di Bartolomeo S, Guggino G, Ciccia F, Triolo G, Cipriani P, Giacomelli R. Di Benedetto P, et al. Among authors: panzera n. Arthritis Res Ther. 2018 Oct 3;20(1):223. doi: 10.1186/s13075-018-1719-4. Arthritis Res Ther. 2018. PMID: 30285896 Free PMC article.